We’re honored to be featured in The Lens Magazine, by LSI’s Alumni Innovator Spotlight highlighting how SOMAVAC, under the leadership of CEO Elizabeth Hoff, is revolutionizing one of the most overlooked aspects of breast cancer care: post-surgical fluid management. For…
Smart Surgical Drainage; Remove Drains Sooner
Modernizing surgical recovery with a proven solution that shortens drain duration, simplifies care, and improves satisfaction for patients and providers alike.
Transforming Post-Surgical Recovery in Breast Cancer Surgery. A Better Tool for Better Patient Experience and Outcomes
Jane Berz, MSN, RN, FNCBCChair of the BoardSOMAVAC Medical Solutions, Inc
Frankie Mead – Welcome to the Team!
We are pleased to welcome Frankie Mead as our new VP of Sales! Frankie comes to us with 25 years of sales leadership expertise in the Plastic Surgery industry. He has spent years building and scaling high-performance, award-winning medical device…
SOMAVAC® Named One of “Five Companies to Watch” from LSI Market Insights
At the core of LSI’s Emerging Medtech Summits are our innovators. This year, 362 early and growth-stage companies took the stage to share how their technologies aim to improve outcomes and extend lives. With so many impressive presentations, our Market…
LSI: SOMAVAC® Redefining Post-Surgical Recovery for Breast Cancer Patients
Under the direction of CEO Elizabeth Hoff, SOMAVAC is challenging the status quo of post-surgical care with its innovative negative pressure solutions. By improving the patient experience and reducing complications associated with seromas, SOMAVAC addresses “the most ignored known problem…
SOMAVAC® Selected to Present at TLSF 2024
SOMAVAC® presenting at the 13th Annual Texas Life Science Forum, co-hosted by BioHouston and Rice Alliance, is Texas’ premier life science and health-tech event, taking place on November 7, 2024 to unite industry professionals, investors, and executives.
SOMAVAC® Receives Strong Reception at ASPS Annual Meeting
There was strong recognition at ASPS that seroma mitigation and elimination are essential to transforming outcomes for breast reconstruction patients. Attendees were particularly excited by SOMAVAC’s FDA-cleared technology.
SOMAVAC® CEO Elizabeth Hoff Presents at LSI Europe: Technology Receives Enthusiastic Response
Elizabeth Hoff’s presentation focused on SOMAVAC’s negative pressure wound therapy device, which is designed to address the unmet needs of patients recovering from large flap surgeries, including breast cancer reconstructions.
SOMAVAC® Welcomes Dr. Aldona Spiegel as New Strategic Advisor
We are honored to have Dr. Spiegel on board and look forward to her guidance as we continue to push the boundaries of patient care and innovation. Dr. Spiegel’s passion for advancing medical technology aligns perfectly with SOMAVAC’s commitment to…
End of content
End of content
